Clinical Trials Directory

Trials / Completed

CompletedNCT03985995

Pain Response to Cannabidiol in Induced Acute Nociceptive Pain, Allodynia and Hyperalgesia By Using a Model Mimicking Acute Pain in Healthy Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study is to investigate the effect of CBD on acute pain in healthy volunteers in a well-established acute pain model.

Detailed description

There are no studies investigating Cannabidiol (CBD) in an acute pain model in human beings. This is however of great clinical value because: 1. Patients are often treated insufficiently with the commonly used analgesics in acute pain therapy or the available selection of analgesics is limited by their contraindications and side-effects. 2. CBD could be an option to optimize pain therapy if the pain relief is not satisfactory. 3. CBD in contrast to ∆9-tetrahydrocannabinol (THC) has only few side effects and due to a possible dose reduction of other analgesics patients might benefit from a better side-effect profile. This study is to investigate the effect of CBD on acute pain in healthy volunteers in a well-established acute pain model.

Conditions

Interventions

TypeNameDescription
DRUGCBD 800 mg p.ocannabidiol solution 100 mg/ml 8 ml in single-dose containers for per os administration. After a washout period of at least two weeks, the treatment group will be receiving a single-dose of the placebo solution 8 ml as a second intervention.
DRUGPlacebo p.osingle dose of oral placebo solution 8 ml matched to the IMP. After a washout period of at least two weeks, the control intervention group will be receiving the cannabidiol solution 100 mg/ml 8 ml as a second intervention.

Timeline

Start date
2019-09-16
Primary completion
2019-12-23
Completion
2019-12-23
First posted
2019-06-14
Last updated
2020-01-29

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03985995. Inclusion in this directory is not an endorsement.

Pain Response to Cannabidiol in Induced Acute Nociceptive Pain, Allodynia and Hyperalgesia By Using a Model Mimicking Ac (NCT03985995) · Clinical Trials Directory